| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/09/2011 | EP2292639A1 Tubulisine derivatives as anticancer drugs |
| 03/09/2011 | EP2292638A2 MAGE-C2 antigenic peptides and uses thereof |
| 03/09/2011 | EP2292631A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 03/09/2011 | EP2292595A1 Potassium channel modulators |
| 03/09/2011 | EP2292275A2 Protecting therapeutic compositions from host-mediated inactivation |
| 03/09/2011 | EP2292273A2 Remodeling and glycoconjugation of peptides |
| 03/09/2011 | EP2292271A2 Remodelling and glycoconjugation of an antibody |
| 03/09/2011 | EP2292259A2 Complement receptor 2 targeted complement modulators |
| 03/09/2011 | EP2292257A2 Compositions and methods for dermatological wound healing |
| 03/09/2011 | EP2292256A2 High mannose proteins and methods of making high mannose proteins |
| 03/09/2011 | EP2292255A2 Stable therapeutical proteins |
| 03/09/2011 | EP2292254A2 Stabilized pharmaceutical peptide compositions |
| 03/09/2011 | EP2292253A2 Stabilized pharmaceutical peptide compositions |
| 03/09/2011 | EP2292252A2 Unitary combination of FSH and hCG |
| 03/09/2011 | EP2292251A1 Combination therapy using anti-angiogenic agents and TNF-alpha |
| 03/09/2011 | EP2292250A1 Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline parvovirus and feline herpes virus |
| 03/09/2011 | EP2292249A1 Non-cytotoxic protein conjugates |
| 03/09/2011 | EP2292247A2 Immunizing composition and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 03/09/2011 | EP2292233A2 Pharmaceutical uses of N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine |
| 03/09/2011 | EP2292216A2 Stable pharmaceutical composition containing factor VIII |
| 03/09/2011 | EP2292215A2 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 03/09/2011 | EP2291523A1 Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 03/09/2011 | EP2291512A2 Biomimetic cell scaffolds |
| 03/09/2011 | EP2291399A2 Multivalent fibronectin based scaffold domain proteins |
| 03/09/2011 | EP2291396A1 A modified galectin-2 and uses thereof |
| 03/09/2011 | EP2291395A1 Novel and powerful mhc-class ii petptides derived from survivin |
| 03/09/2011 | EP2291392A1 Bifunctional molecules for inhibiting hiv entry |
| 03/09/2011 | EP2291188A2 Compositions and methods to protect cells by blocking entry of pathogen proteins |
| 03/09/2011 | EP2291075A2 Gastrin releasing peptide compounds |
| 03/09/2011 | EP2173349B1 Antitumour combinations containing a vegf inhibiting agent and irinotecan |
| 03/09/2011 | EP2117510B1 Parenteral pharmaceutical composition and method for preparing the same |
| 03/09/2011 | EP1842857B1 Mutant interferon proteins and use thereof |
| 03/09/2011 | EP1796713B1 Use of gilz proteinto modulate an antigen-specific immune response |
| 03/09/2011 | EP1748069B1 Follistatin mutant polypeptide |
| 03/09/2011 | EP1742651B1 Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment |
| 03/09/2011 | EP1709177B1 Dna-sequence and recombinant production of group 4 major allergens from cereals |
| 03/09/2011 | EP1688498B1 A recombinant protein with cancer suppression action, its encoding gene and use |
| 03/09/2011 | EP1596880B1 Methods and compositions for suppressing fibrocyte differentiation |
| 03/09/2011 | EP1575548B1 Compositions and methods for promoting neuronal outgrowth |
| 03/09/2011 | EP1491206B9 Use of peptide derivatives for inducing cell differentiation |
| 03/09/2011 | EP1364963B1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 03/09/2011 | EP1355910B1 Formulation of boronic acid compounds |
| 03/09/2011 | EP1315513B1 "pseudo"-native chemical ligation |
| 03/09/2011 | EP1276887B1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 03/09/2011 | EP1181320B1 Somatic transgene immunization and related methods |
| 03/09/2011 | CN101983968A Preparation method of sepia oligopeptide by enzymatic hydrolysis and application thereof |
| 03/09/2011 | CN101983722A Composition for preventing and treating joint soft tissue injury and complications thereof |
| 03/09/2011 | CN101983721A Desert cistanche calcium composition having functions of fatigue resistance and calcium supplement |
| 03/09/2011 | CN101068560B Method of screening toxin-neutralizing peptide, STX2 inhibitory peptide and Vero toxin-neutralizing agent |
| 03/08/2011 | USRE42211 Relating to binding proteins for recognition of DNA |
| 03/08/2011 | US7902441 Group of recessive oncogenes, Fus1, 101F6, Gene 21 (NPRL2), Gene 26 (CACNA2D2), Luca 1 (HYAL1), Luca 2 (HYAL2), PL6 ,123F2 (RaSSFI), SEM A3 and Beta* (BLU), defined by homozygous deletion in lung cancer, have been located, isolated at 3p21.3 |
| 03/08/2011 | US7902349 Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly) |
| 03/08/2011 | US7902332 Reacting thiol-reactive terminus of linker with a polypeptide and fluorine-substituted aldehyde |
| 03/08/2011 | US7902329 Oligopeptide tyrosinase inhibitors and uses thereof |
| 03/08/2011 | US7902328 Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
| 03/08/2011 | US7902327 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 03/08/2011 | US7902185 Treatment of neurodegenerative diseases using proteasome modulators |
| 03/08/2011 | US7902172 Method of promoting bone growth with hyaluronic acid and growth factors |
| 03/08/2011 | US7902165 Inhibiting of the proliferation of tumor cells is mediated by upregulation of the activity of p53 |
| 03/08/2011 | US7902164 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/08/2011 | US7902163 Antisense modulation of superoxide dismutase 1, soluble expression |
| 03/08/2011 | US7902160 ENA nucleic acid drugs modifying splicing in mRNA precursor |
| 03/08/2011 | US7902156 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 03/08/2011 | US7902155 Therapeutic methods using cyclosporine components |
| 03/08/2011 | US7902154 Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same |
| 03/08/2011 | US7902153 Alpha-conotoxin peptides |
| 03/08/2011 | US7902152 Use of cobratoxin as an analgesic |
| 03/08/2011 | US7902151 Methods and compositions for modulating immunity |
| 03/08/2011 | US7902150 Medicaments and proteins based on TGF-β monomers for the treatment of wounds |
| 03/08/2011 | US7902149 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 03/08/2011 | US7902148 Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent |
| 03/08/2011 | US7902146 Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties |
| 03/08/2011 | US7902145 Terminal sterilization of injectable collagen products |
| 03/08/2011 | US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 03/08/2011 | US7902143 Cancer antigen peptide and the use thereof |
| 03/08/2011 | US7901943 Materials and methods for controlling isotope effects during fractionation of analytes |
| 03/08/2011 | US7901918 Proteases and variants thereof |
| 03/08/2011 | US7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/08/2011 | US7901911 Polynucleotide encoding IL-6 receptor/IL-6 fusion protein |
| 03/08/2011 | US7901898 Tuberculosis diagnostic test |
| 03/08/2011 | US7901879 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 03/08/2011 | US7901718 Process for the extraction, purification and enzymatic modification of soy 7S globulin α′ subunit for use as hypocholesterolemizing agent |
| 03/08/2011 | US7901693 Compositions and methods for WT1 specific immunotherapy |
| 03/08/2011 | US7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 03/08/2011 | US7901688 Rage fusion proteins |
| 03/08/2011 | US7901685 Methods for assaying inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion |
| 03/08/2011 | US7901683 Methods of inhibiting amyloid toxicity |
| 03/08/2011 | US7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
| 03/08/2011 | US7901680 Dock-and-lock (DNL) vaccines for cancer therapy |
| 03/08/2011 | US7901676 Therapeutic composition for the treatment of rheumatoid arthritis |
| 03/08/2011 | US7901675 Method of using coenzyme Q10 to treat Huntington's disease |
| 03/08/2011 | US7901674 Aldehyde-fixed platelets with internalized paramagnetic or magnetic nanoparticles |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | US7901670 purification from a recombinant human interferon beta-containing culture by performing affinity chromatography and reversed-phase high-performance liquid chromatography |
| 03/08/2011 | US7901669 Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing OSMRβ as a subunit, and applications thereof |
| 03/08/2011 | CA2498565C Composition for treating virus infection disease comprising jab1 |
| 03/08/2011 | CA2465667C New peptides - analogs of human growth hormone-releasing hormone |
| 03/08/2011 | CA2463987C Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
| 03/08/2011 | CA2440355C Fibrate-statin combinations with reduced fed-fasted effects |
| 03/08/2011 | CA2413334C Stabilized interleukin 2 |